262 related articles for article (PubMed ID: 16753595)
1. Galectin-3 and Ki-67 expression in multiglandular parathyroid lesions.
Saggiorato E; Bergero N; Volante M; Bacillo E; Rosas R; Gasparri G; Orlandi F; Papotti M
Am J Clin Pathol; 2006 Jul; 126(1):59-66. PubMed ID: 16753595
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 expression in parathyroid carcinoma: immunohistochemical study of 26 cases.
Bergero N; De Pompa R; Sacerdote C; Gasparri G; Volante M; Bussolati G; Papotti M
Hum Pathol; 2005 Aug; 36(8):908-14. PubMed ID: 16112008
[TBL] [Abstract][Full Text] [Related]
3. Defining a molecular phenotype for benign and malignant parathyroid tumors.
Fernandez-Ranvier GG; Khanafshar E; Tacha D; Wong M; Kebebew E; Duh QY; Clark OH
Cancer; 2009 Jan; 115(2):334-44. PubMed ID: 19107770
[TBL] [Abstract][Full Text] [Related]
4. Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors.
Wang O; Wang CY; Shi J; Nie M; Xia WB; Li M; Jiang Y; Guan H; Meng XW; Xing XP
Chin Med J (Engl); 2012 Aug; 125(16):2895-901. PubMed ID: 22932087
[TBL] [Abstract][Full Text] [Related]
5. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
Aron M; Kapila K; Verma K
Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
[TBL] [Abstract][Full Text] [Related]
6. Adrenomedullin immunoreactivity tissue distribution in parathyroids of the patients with primary hyperparathyroidism.
Letizia C; Ricci F; De Toma G; Cianci R; Alo P; Celi M; Panzironi G; Mingazzini PL; D'Erasmo E; Mazzuoli GF
Horm Metab Res; 2004 Jul; 36(7):480-4. PubMed ID: 15305232
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of parathyroid hormone and chromogranin A in secondary hyperparathyroidism: a functional marker for secretory activity of hyperplastic nodules.
Tanaka R; Umemura S; Kakuta T; Fujisaki T; Sakai H; Saitoh A; Osamura RY
Pathol Res Pract; 2003; 199(2):93-9. PubMed ID: 12747471
[TBL] [Abstract][Full Text] [Related]
8. Expression of nm23 antimetastatic gene product in parathyroid hyperplasia, adenoma and carcinoma. An immunohistological assessment.
Al-Maghrabi JA; Asa SL
Saudi Med J; 2005 May; 26(5):728-31. PubMed ID: 15951858
[TBL] [Abstract][Full Text] [Related]
9. [The use of flow cytometry in the study of parathyroid hyperplasia and adenomas].
Mangili F; Sassi I; Schiaffino E; Zogno C; Cantaboni A; Schmid C
Pathologica; 1992; 84(1092):459-65. PubMed ID: 1491887
[TBL] [Abstract][Full Text] [Related]
10. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
11. Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study.
Schmid KW; Hittmair A; Ladurner D; Sandbichler P; Gasser R; Tötsch M
Virchows Arch A Pathol Anat Histopathol; 1991; 418(4):295-9. PubMed ID: 2024450
[TBL] [Abstract][Full Text] [Related]
12. Expression of the alpha- and beta-subunits of human chorionic gonadotropin by subsets of parathyroid cells in states of hyperparathyroidism.
Carlinfante G; Lampugnani R; Azzoni C; Aprile MR; Brandi ML; Bordi C
J Pathol; 1998 Aug; 185(4):389-93. PubMed ID: 9828837
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.
Vasef MA; Brynes RK; Sturm M; Bromley C; Robinson RA
Mod Pathol; 1999 Apr; 12(4):412-6. PubMed ID: 10229506
[TBL] [Abstract][Full Text] [Related]
14. Study of parathyroid transcription factor Gcm2 expression in parathyroid lesions.
Nonaka D
Am J Surg Pathol; 2011 Jan; 35(1):145-51. PubMed ID: 21164298
[TBL] [Abstract][Full Text] [Related]
15. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism.
Szende B; Farid P; Végso G; Perner F; Kopper L
Pathol Oncol Res; 2004; 10(2):98-103. PubMed ID: 15188026
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hyperplasia, adenomas, and carcinomas: differential expression of p27Kip1 protein.
Erickson LA; Jin L; Wollan P; Thompson GB; van Heerden JA; Lloyd RV
Am J Surg Pathol; 1999 Mar; 23(3):288-95. PubMed ID: 10078919
[TBL] [Abstract][Full Text] [Related]
18. [Morphologic changes in the parathyroid glands in primary hyperparathyroidism].
Odinokova VA; Dmitrieva NP; Kalinin AP; Astakhov AF
Arkh Patol; 1976; 38(7):18-24. PubMed ID: 1016092
[TBL] [Abstract][Full Text] [Related]
19. The use of a combination of Ki-67, Galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor.
Cui W; Lu X; Zheng S; Ma Y; Liu X; Zhang W
Clin Lab; 2012; 58(5-6):419-26. PubMed ID: 22783570
[TBL] [Abstract][Full Text] [Related]
20. Selected markers of proliferation and apoptosis in the parathyroid lesions: a spatial visualization and quantification.
Kaczmarek E; Lacka K; Majewski P; Trzeciak P; Gorna A; Jarmolowska-Jurczyszyn D; Kluk A
J Mol Histol; 2008 Oct; 39(5):509-17. PubMed ID: 18726191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
